Palisade Bio (PALI) EBITDA Margin (QoQ) (2011 - 2020)
Palisade Bio (PALI) EBITDA Margin (QoQ) (2011 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Palisade Bio |
391.02 Mn |
261.45 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2020 |
-8.39 Mn |
| Sep 30, 2020 |
-1.47 Mn |
| Jun 30, 2020 |
4.78 Mn |
| Mar 31, 2020 |
-4.44 Mn |
| Dec 31, 2019 |
-1.07 Mn |
| Sep 30, 2019 |
-5.25 Mn |
| Jun 30, 2019 |
10.64 Mn |
| Mar 31, 2019 |
-11.18 Mn |
| Dec 31, 2018 |
6.04 Mn |
| Sep 30, 2018 |
-7.30 Mn |
| Jun 30, 2018 |
8.56 Mn |
| Mar 31, 2018 |
-8.46 Mn |
| Dec 31, 2017 |
407,846.00 |
| Sep 30, 2017 |
18.06 Mn |
| Jun 30, 2017 |
11.67 Mn |
| Mar 31, 2017 |
-24.10 Mn |
| Dec 31, 2016 |
14.71 Mn |
| Sep 30, 2016 |
-5.48 Mn |
| Jun 30, 2016 |
11.03 Mn |
| Mar 31, 2016 |
-7.37 Mn |
